244 results on '"Cerri, Michaela"'
Search Results
2. Supplementary Data from Stereotyped B-Cell Receptor Is an Independent Risk Factor of Chronic Lymphocytic Leukemia Transformation to Richter Syndrome
3. The genetics of nodal marginal zone lymphoma
4. Decreased function of Fas and variations of the perforin gene in adult patients with primary immune thrombocytopenia
5. Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia
6. Molecular characterization of post-transplant lymphoproliferative disorders of donor origin occurring in liver transplant recipients
7. 14q32 Translocations and risk of Richter transformation in chronic lymphocytic leukaemia
8. Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus Type 8-Positive Solid Lymphomas: A Tissue-Based Variant of Primary Effusion Lymphoma
9. Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome
10. Early stage chronic lymphocytic leukaemia carrying unmutated IGHV genes is at risk of recurrent infections during watch and wait
11. Epigenetic inactivation of suppressors of cytokine signalling in Philadelphia-negative chronic myeloproliferative disorders
12. JAK2V617F in idiopathic venous thromboembolism occurring in the absence of inherited or acquired thrombophilia
13. JAK2V617F mutation in leukaemic transformation of philadelphia-negative chronic myeloproliferative disorders
14. Aberrant somatic hypermutation in post-transplant lymphoproliferative disorders
15. Incidence of novel N-glycosylation sites in the B-cell receptor of lymphomas associated with immunodeficiency
16. Frequent aberrant promoter hypermethylation of O6-methylguanine-DNA methyltransferase and death-associated protein kinase genes in immunodeficiency-related lymphomas
17. Molecular histogenesis of plasmablastic lymphoma of the oral cavity
18. Molecular histogenesis of posttransplantation lymphoproliferative disorders
19. Clinical, pathological, and biological characterization of Richter syndrome developing after ibrutinib treatment for relapsed chronic lymphocytic leukemia
20. Clinical, pathological, and biological characterization of Richter syndrome developing after ibrutinib treatment for relapsed chronic lymphocytic leukemia
21. Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia
22. Mutations of BRAF and BIRC3 Identify a Subgroup of Chronic Lymphocytic Leukemia with Very Poor Prognosis upon FCR Treatment
23. Mutational status of IGHV is the most reliable prognostic marker in trisomy 12 chronic lymphocytic leukemia
24. Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: evidences from long term follow-up
25. The Genetics of Nodal Marginal Zone Lymphoma
26. Decreased function of Fas and variations of the perforin gene in adult patients with primary immune thrombocytopenia
27. Clinical impact of small subclones harboring NOTCH1 , SF3B1 or BIRC3 mutations in chronic lymphocytic leukemia
28. BRAF and BIRC3 Mutations Stratify a Poor Prognostic Subgroup in FCR Treated Chronic Lymphocytic Leukemia
29. Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma
30. Molecular analysis of immunoglobulin variable genes in human immunodeficiency virus-related non-Hodgkin's lymphoma reveals implications for disease pathogenesis and histogenesis
31. Aberrant somatic hypermutation in transformation of follicular lymphoma and chronic lymphocytic leukemia to diffuse large B-cell lymphoma
32. The NF-κB negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas
33. Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome
34. MGA, a suppressor ofMYC, is recurrently inactivated in high risk chronic lymphocytic leukemia
35. Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: evidences from long term follow‐up.
36. Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness
37. Mutations of NOTCH1 Are An Independent Predictor of Survival in Chronic Lymphocytic Leukemia
38. Genomic profiling of Richter's syndrome: recurrent lesions and differences with de novo diffuse large B-cell lymphomas
39. Stereotyped B-Cell Receptor Is an Independent Risk Factor of Chronic Lymphocytic Leukemia Transformation to Richter Syndrome
40. The Prognostic Value of TP53 Mutations in Chronic Lymphocytic Leukemia Is Independent of Del17p13: Implications for Overall Survival and Chemorefractoriness
41. Occult hepatitis B virus infection of peripheral blood mononuclear cells among treatment-naïve patients with chronic lymphocytic leukemia
42. Hairy cell leukaemia complicated by anti-MAG paraproteinemic demyelinating neuropathy: resolution of neurological syndrome after cladribrine treatment
43. Usefulness of JAK2V617F mutation in distinguishing idiopathic erythrocytosis from polycythemia vera
44. 14q32 Translocations and risk of Richter transformation in chronic lymphocytic leukaemia
45. The Prognostic Value of TP53 Mutations in Chronic Lymphocytic Leukemia (CLL) Is Independent of del17p13: Implications for Overall Survival and Chemorefractoriness
46. The NF-κB Negative Regulator TNFAIP3 (A20) is Commonly Inactivated by Somatic Mutations and Genomic Deletions in Marginal Zone B-Cell Lymphomas
47. Genome Wide-DNA Profiling of Richter’s Syndrome-Diffuse Large B-Cell Lymphoma (RS-DLBCL): Differences with De Novo DLBCL and Possible Mechanisms of Transformation from Chronic Lymphocytic Leukemia (CLL).
48. Telomere Length Is An Independent Predictor of Survival, Treatment Requirement and Richter’s Syndrome Transformation in Chronic Lymphocytic Leukemia.
49. Usage of IGHV4-39 with Stereotypic B Cell Receptor Is An Independent Risk Factor of Chronic Lymphocytic Leukemia Transformation to Richter Syndrome
50. Molecular, Phenotypic and Clinical Predictors of Richter Syndrome (RS) in Chronic Lymphocytic Leukemia (CLL).
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.